NCT04907903

Brief Summary

This study aims is the evaluation of the efficacy and feasibility of RinasciMENTE, the Randomized Controlled Clinical Trial compared with a waiting list control group.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 1, 2021

Completed
1.3 years until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

July 27, 2022

Status Verified

July 1, 2022

Enrollment Period

3 months

First QC Date

April 7, 2021

Last Update Submit

July 26, 2022

Conditions

Keywords

COVID-19internet-based interventioncognitive-behavioral therapy

Outcome Measures

Primary Outcomes (1)

  • Outcome Questionnaire (OQ-45)

    It measures the changes in adult patients thanks to intervention.

    Baseline, 2 months follow-up, 12 months follow-up

Secondary Outcomes (6)

  • Perceived stress scale (PSS)

    Baseline, 2 months follow-up, 12 months follow-up

  • Emotional regulation questionnaire (ERQ)

    Baseline, 2 months follow-up, 12 months follow-up

  • Depression Anxiety Stress Scales-Short Version (DASS-21)

    Baseline, 2 months follow-up, 12 months follow-up

  • Fear of COVID-19 Scale (FCV-19S)

    Baseline, 2 months follow-up, 12 months follow-up

  • General Self-efficacy Scale (GSES)

    Baseline, 2 months follow-up, 12 months follow-up

  • +1 more secondary outcomes

Study Arms (2)

RinasciMENTE

EXPERIMENTAL

Participants will receive the internet-based intervention.

Other: internet-based intervention

Waiting-list

NO INTERVENTION

Participants will no receive the internet-based intervention.

Interventions

Intervention consists in 8 weekly online cognitive-behavioral modules (for a total duration of 2 months).

RinasciMENTE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or over and both gender
  • Italian mother-tongue
  • Score 14 or less on Patients Health Questionnaire-9 (PHQ-9)
  • Internet access and basic informatic ability to navigate the internet platform
  • Must be able to complete a phone interview

You may not qualify if:

  • Having severe and mental impairments, psychiatric condition and neurological disorder
  • Not be able to use a computer or do not have internet access
  • Not be able to complete a phone interview
  • Score 15 or more on PHQ-9

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

April 7, 2021

First Posted

June 1, 2021

Study Start

September 1, 2022

Primary Completion

December 1, 2022

Study Completion

June 1, 2023

Last Updated

July 27, 2022

Record last verified: 2022-07